Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal cancer

KRYSTAL-1: Adagrasib as monotherapy or combined with cetuximab in patients with CRC harboring a KRASG12C mutation

Neoadjuvant chemotherapy with CapeOx alone vs standard chemoradiotherapy (CRT) with Capecitabine for patients with LARC

OncoAlert and ecancer - ESMO 2021 Day 4

FOLFOXIRI + bevacizumab + atezolizumab versus FOLFOXIRI + bevacizumab as first-line treatment of unresectable mCRC patients

ESMO President: What to watch for at ESMO 2021

Oesophageal and gastric cancers

BEACON-CRC: first-line bevacizumab in colorectal cancer treatment

OncoAlert and ecancer weekly round up for July 12- July 18, 2021

Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600E metastatic colorectal cancer

OncoAlert and ecancer weekly round up for July 1- July 10, 2021

Study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic oesophageal cancer